Physician profile
Jonathan D Wigderson
NPI 1073574679
$10,809.97
in general payments reported to CMS, 2019-2025
25 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,221 · 2020: $747 · 2021: $2,866 · 2022: $313 · 2023: $787 · 2024: $466 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,096.19 | 2019-2025 | Matrixrib, Na, Tfn-Advance |
| Synthes USA Products LLC | $2,840.56 | 2020-2021 | |
| Depuy Synthes Sales INC. | $1,420.16 | 2019-2024 | Na, Tfn-Advance, Vivigen Mis Delivery System |
| Lifenet Health | $470.37 | 2022-2025 | Allograft Vmis Delivery System |
| Djo, LLC | $113.24 | 2019-2025 | Cmf |
| Next Science LLC | $112.00 | 2021 | |
| Tela Bio, INC. | $88.27 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $79.07 | 2019-2023 | Na |
| Amgen INC. | $75.98 | 2023-2024 | Prolia, Evenity |
| Skeletal Dynamics INC | $64.42 | 2023 | Geminus, Implate, Ijs |
| Fidia Pharma USA INC. | $58.95 | 2019-2022 | |
| Globus Medical, INC. | $56.64 | 2019 | |
| Davol INC. | $56.25 | 2021-2024 | Arista Ah Flexitip |
| Zimvie INC. | $41.68 | 2022 | |
| Bioventus LLC | $39.72 | 2020-2025 | Xcell |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $32.62 | 2023 | Dynasplint |
| Acelrx Pharmaceuticals, INC. | $30.47 | 2019 | |
| Orthofix Medical, INC. | $23.23 | 2024 | Spinal-Stim |
| Medtronic, INC. | $20.89 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.55 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $18.28 | 2020 | |
| Horizon Therapeutics Plc | $15.48 | 2023 | Krystexxa |
| Si-Bone, INC. | $15.30 | 2020 | |
| Merck Sharp & Dohme LLC | $12.70 | 2023 | Bridion |
| Heraeus Medical, LLC. | $7.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Wigderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.